Cancer Science & Research
Open AccessAnticipatory Oncology: A New Paradigm for Hidden Breast Cancer Progression
Authors: Philip de Melo.
Abstract
Breast cancer progression is often monitored using observable clinical indicators such as imaging findings, laboratory values, and biomarker trajectories. However, many critical biological processes remain concealed within latent disease dynamics that are not directly measurable. This study presents a latent-state analytical framework for the recovery of hidden states in breast cancer using noisy and partially observed clinical data. The proposed approach integrates stochastic state-space modeling, longitudinal signal reconstruction, and artificial intelligence–driven analytics to estimate the underlying disease activity from observable variables.
The framework separates measurable observations from hidden biological processes through coupled process and observation equations, allowing reconstruction of latent trajectories associated with disease evolution. By incorporating process noise, observational uncertainty, and nonlinear progression dynamics, the model captures variations that are frequently missed by deterministic approaches. The methodology was evaluated on breast cancer datasets containing longitudinal clinical and diagnostic information. Hidden-state recovery enabled the identification of subtle transitions in disease dynamics prior to the appearance of major clinical deterioration.
Results demonstrate that latent-state reconstruction improves sensitivity to concealed progression patterns and enhances the interpretability of temporal disease evolution. The method also provides a foundation for anticipatory analytics by estimating probabilistic future trajectories rather than relying solely on static observations. These findings suggest that hidden-state recovery may support earlier intervention, more individualized monitoring strategies, and improved predictive modeling in oncology. The proposed framework illustrates how stochastic artificial intelligence and latent dynamic modeling can contribute to next-generation breast cancer analytics and precision medicine.
Editor-in-Chief
View full editorial board →